Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 2/2018

01-02-2018

Imaging mimics of pancreatic ductal adenocarcinoma

Authors: Namita S. Gandhi, Myra K. Feldman, Ott Le, Gareth Morris-Stiff

Published in: Abdominal Radiology | Issue 2/2018

Login to get access

Abstract

Pancreatic ductal adenocarcinoma is the most common primary malignancy of the pancreas. The classic imaging features are a hypovascular mass with proximal ductal dilatation. Different pancreatic pathologies can mimic the imaging appearance of carcinoma including other tumors involving the pancreas (pancreatic neuroendocrine tumors, lymphoma, metastasis, and rare tumors like pancreatic acinar cell carcinoma and solid pseudopapillary tumors), inflammatory processes (chronic pancreatitis and autoimmune pancreatitis), and anatomic variants (annular pancreas). Differentiation between these entities can sometimes be challenging due to overlap of imaging features. The purpose of this article is to describe the common entities that can mimic pancreatic cancer on imaging with illustrative examples and to suggest features that can help in differentiation of these entities.
Literature
1.
De Juan C, Sanchez M, Miquel R, et al. (2008) Uncommon tumors and pseudotumoral lesions of the pancreas. Curr Probl Diagn Radiol 37(145):164
2.
Feldman MK, Gandhi NS (2016) Imaging evaluation of pancreatic cancer. Surg Clin N Am 96:1235–1256CrossRefPubMed
3.
4.
Gerritsen A, Molenaar QI, Bollen T (2014) Preoperative characteristics of patients with presumed pancreatic cancer but ultimately benign disease: a multicenter series of 344 pancreatoduodenectomies. Ann Surg Oncol 21:3999–4006CrossRefPubMed
5.
Manzia TM, Toti L, Lenci I, et al. (2010) Benign disease and unexpected histological findings after pancreaticoduodenectomy: the role of endoscopic ultrasound fine needle aspiration. Ann R Coll Surg Engl 92(4):295–301CrossRefPubMedPubMedCentral
6.
National comprehensive cancer network clinical practice guidelines in oncology: neuroendocrine tumors version 3.2017-June 13, 2017
7.
Sheth S, Hruban RK, Fishman EK (2002) Helical CT of islet cell tumors of the pancreas: typical and atypical manifestations. Am J Rontegenol 179:721–730
8.
Lewis RB, Lattin GE Jr, E Paal (2010) Pancreatic endocrine tumors: radiologic-clinical pathologic correlation. RadioGraphics 30(6):1445–1464CrossRefPubMed
9.
Jeon SK, Lee JM, Joo I, et al. (2017) Nonhypervascular pancreatic neuroendocrine tumors: differential diagnosis from pancreatic ductal adenocarcinomas at mr imaging—retrospective cross-sectional study. Radiology 284(1):77–87CrossRefPubMed
10.
Kim JH, Eun HW, Kim YJ, et al. (2016) Pancreatic neuroendocrine tumor (PNET): staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma. Eur Radiol 26:1338–1347CrossRefPubMed
11.
Tsitouridis I, Diamantopoulou A, Michaelides M, et al. (2010) Pancreatic metastases: CT and MRI findings. Diagnos Interv Radiol 16(1):45–51
12.
Scatarige JC, Horton KM, Sheth S, et al. (2001) Pancreatic parenchymal metastases observations on helical CT. Am J Roentgenol 176(3):695–699CrossRef
13.
Ahmed S, Johnson PT, Hruban R, et al. (2013) Metastatic disease to the pancreas: pathologic spectrum and CT patterns. Abdom Imaging 38:144–153CrossRefPubMed
14.
Dawson IM, Cornes JS, Morson BC (1961) Primary malignant lymphoid tumors of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg 49:80–89CrossRefPubMed
15.
Behms KE, Sarr MG, Strickler JG (1994) Pancreatic lymphoma: is it a surgical disease? Pancreas 9:662–667CrossRef
16.
Merkle EM, Bender GN, Brambs HJ (2000) Imaging findings in pancreatic lymphoma: differential aspects. Am J Roentgenol 174(3):671–675CrossRef
17.
Van Beers B, Lalonde L, Soyer P, et al. (1993) Dynamic CT in pancreatic lymphoma. J Comput Assist Tomogr 17:94–97CrossRefPubMed
18.
19.
Marchegiani G, Andrianello S, Massignani M, et al. (2016) Solid pseudopapillary tumors of the pancreas: specific pathological features predict the likelihood of postoperative recurrence. J Surg Oncol 114(5):597–601CrossRefPubMed
20.
Buetow PC, Buck JL, Pantongrag-Brown L, et al. (1996) Solid and papillary epithelial neoplasm of the pancreas: imaging-pathologic correlation on 56 cases. Radiology 199(3):707–711CrossRefPubMed
21.
Ganeshan DM, Paulson E, Tamm EP, et al. (2013) Solid pseudopapillary tumors of the pancreas: current update. Abdom Imaging 38:1373–1382CrossRefPubMed
22.
Cantisani V, Mortele KJ, Levy A, et al. (2003) MR imaging features of solid pseudopapillary tumor of the pancreas in adult and pediatric patients. Am J Roentgenol 181(2):395–401CrossRef
23.
Choi JY, Kim MJ, Kim JH, et al. (2006) Solid pseudopapillary tumor of the pancreas: typical and atypical manifestations. Am J Roentgenol 187(2):W178–W186CrossRef
24.
Tatli S, Mortele KJ, Levy AD, et al. (2005) CT and MRI features of pure acinar cell carcinoma of the pancreas in adults. Am J Roentgenol 184:511–519CrossRef
25.
Bhosale P, Balachandran A, Wang H, et al. (2013) CT imaging features of acinar cell carcinoma and its hepatic metastases. Abdom Imaging 38:1383–1390CrossRefPubMed
26.
Chiou YY, Jen-Huey C, Jen-I H, et al. (2004) Acinar cell carcinoma of the pancreas: clinical and computed tomography manifestations. J Comput Assist Tomogr 28(2):180–186CrossRefPubMed
27.
Barral , et al. (2016) Imaging features of rare pancreatic tumors. Diagnos Interv Imaging 97:1259–1273CrossRef
28.
Choi JY, Kim MJ, Lee JY, et al. (2009) Typical and atypical manifestations of serous cystadenomas of the Pancreas: imaging findings with pathologic correlation. Am J Roentgenol 193:136–142CrossRef
29.
Kim HJ, Lee DH, Ko YT, et al. (2008) CT of serous cystadenoma of the pancreas and mimicking masses. Am J Roentegnol 190:406–412CrossRef
30.
31.
Ginat DT, Bokhari A, Bhatt S, et al. (2011) Imaging features of solitary fibrous tumors. Am J Roentgenol 196:487–495CrossRef
32.
Ichikawa T, Sou H, Araki T, et al. (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221:107–116CrossRefPubMed
33.
Kim Jai K, Ersan Altun, Jorge Elias, et al. (2007) Focal pancreatic mass: Distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. JMRI 26(2):313–322CrossRefPubMed
34.
Fattahi R, Balci NC, Perman WH, et al. (2009) Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging 29(2):350–356CrossRefPubMed
35.
Okazaki K, Uchida K, Koyabu M, Miyoshi H, et al. (2011) Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol 46(3):277–288CrossRefPubMed
36.
Shimosegawa T, Chari ST, Frulloni L, et al. (2011) International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40(3):352–358CrossRefPubMed
37.
Sahani DV, Kalva SP, Farrell J, et al. (2004) Autoimmune pancreatitis: imaging features. Radiology 233:345–352CrossRefPubMed
38.
Vlachou PA, Khalili K, Jang HJ, et al. (2011) IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations. Radiographics 31(5):1379–1402CrossRefPubMed
39.
Kamisawa T, Egawa N, Nakajima H, et al. (2003) Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol 98:2694–2699CrossRefPubMed
40.
Itoh S, Yamakawa K, Shimamoto K, et al. (1994) CT findings in groove pancreatitis: correlation with histopathological findings. J Comput Assist Tomogr 18:911–915CrossRefPubMed
41.
Raman SP, Salaria SN, Hruban RH, et al. (2013) Groove pancreatitis: spectrum of imaging findings and radiology-pathology correlation. Am J Roentgenol 201(1):W29–W39CrossRef
42.
Kim HJ, Byun JH, Park SH, et al. (2007) Focal fatty replacement of the pancreas: usefulness of chemical shift MRI. Am J Roentgenol 188(2):429–432CrossRef
43.
Matsumoto S, Mori H, Miyake H, et al. (1995) Uneven fatty replacement of the pancreas: evaluation with CT. Radiology 194:453–458CrossRefPubMed
44.
Atri M, Nazarnia S, Mehio A, et al. (1994) Hypoechogenic embryologic ventral aspect of the head and uncinate process of the pancreas: in vitro correlation of US with histopathologic findings. Radiology 190:441–444CrossRefPubMed
45.
46.
Sandrasegaran K, Patel A, Fogel EL, et al. (2009) Annular pancreas in adults. Am J Roentgenol 193(2):455–460CrossRef
47.
Metadata
Title
Imaging mimics of pancreatic ductal adenocarcinoma
Authors
Namita S. Gandhi
Myra K. Feldman
Ott Le
Gareth Morris-Stiff
Publication date
01-02-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 2/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1330-1

Other articles of this Issue 2/2018

Abdominal Radiology 2/2018 Go to the issue

OriginalPaper

Applicability of current NCCN Guidelines for pancreatic adenocarcinoma resectability: analysis and pitfalls

OriginalPaper

Pancreatic adenocarcinoma: cross-sectional imaging techniques

OriginalPaper

Response assessment in pancreatic ductal adenocarcinoma: role of imaging

OriginalPaper

Gastroenterology and pancreatic adenocarcinoma: what the radiologist needs to know

OriginalPaper

Imaging of post-operative pancreas and complications after pancreatic adenocarcinoma resection

OriginalPaper

Surgery for pancreatic cancer: critical radiologic findings for clinical decision making
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits